Click the button below to request a report when hardcopies become. Its goal is to change the practice of medicine and it is achieving this primarily by discovering novel medicines that address unmet patient needs. The 2006 amount includes the gain on the sale of this business of. Lanxess investors recent annual reports and quarterly. Relations website, as audio webcasts andor pdf documents for slide presentations. Financial statements of novartis ag 248 annual report photography 262 key dates 2010, contact information and 264. The results in 2006 relate primarily to our former consumer healthcare business, which was sold on december 20, 2006. If this is an annual report, indicate by check mark whether the registrant is a shell company as. View the latest nvs financial statements, income statements and financial ratios.
Novartis ag does not currently have any hardcopy reports on. With the 2015 annual report, values back to 2011 were restated. If you dont have the adobe acrobat reader, click here to quickly download it. Stephan mumenthaler, head economic affairs copenhagen, february 26, 2008. Nvs novartis ag adr annual income statement marketwatch. In 2007, there is a significant risk that generic competition will. Cautionary statement regarding forwardlooking statements the groups reports filed with or furnished to. Ranbaxy annual reports 2007 pdf 02 daiichi sankyo co, ltd.
If this is an annual report, indicate by check mark whether the registrant is a. Your company returned to growth, just as businesses readied to enter chapter 2 of their digital reinventions. View all nvs assets, cash, debt, liabilities, shareholder equity and investments. Financial results pdf 106 kb financial results september 31, 20 financial results pdf 655 kb financial results june 30, 20 finacial results pdf 88,6 kb financial results march 31, 20 financial results pdf 108 kb. Click the button below to request a report when hardcopies become available. Nvs novartis ag adr annual balance sheet marketwatch. Novartis ag adr annual stock financials by marketwatch. Download key corporate publications such as the novartis annual report and form 20f, which contain our complete audited financial statements. Novartis ag adr annual balance sheet by marketwatch.
Novartis ag and its consolidated affiliates publish consolidated financial statements expressed in us dollars. Gsk annual report 2017 05 investor information financial statements governance and remuneration strategic report. As for our indian subsidiary, ranbaxy, we will consolidate its position as the indias top pharmaceutical company. She served as dean and vice chancellor from 2007 to 2017. Novartis international ag novartis annual report 2004. Novartis financial report 1998 contents 1 financial highlights. Novartis international ag novartis annual report 2002. Click the link provided to view the full text version of our annual report.
Our consolidated financial statements responsive to item 18 of this annual report on form 20f annual report are prepared in accordance with international financial reporting standards ifrs as issued by the international. Our annual report 2018 provides a comprehensive overview of novartis, including our. United states position related to the 2007 tax filing. This statistic was assembled from several editions of novartis annual report. Independent assurance report 101 corporate governance corporate governance 103 verwaltungsrat 118. Annex 10 list of companies that have submitted annual reports on. Celgene corporation, headquartered in summit, new jersey, is an integrated global biopharmaceutical company engaged primarily in the discovery, development and commercialization of innovative therapies for the treatment of cancer and inflammatory diseases through nextgeneration solutions in protein homeostasis, immunooncology, epigenetics, immunology and neuroinflammation. Novartis decides to exercise their option to sell their interests to us. In addition, a responsible business supplement, will be.
Novartis has a longstanding commitment to the fight against neglected diseases as exemplified by the largescale coartem malaria initiative, the leprosy donation program, the tb dots partnership and the novartis institute for tropical diseases in singapore which focuses on research on dengue fever, tuberculosis and malaria. Download key corporate publications such as the novartis annual report and form 20f, which contain our complete audited financial. As novartis continues to closely monitor the coronavirus situation, our primary concern is the health and safety of our associates and patients globally. Novartis foundation japan introduced html version of annual report on web site this year and ceased the publication of printed version. Novartis international ag novartis annual report 2003. Approval of the financial statements of novartis ag, and decision on the appropriation of. It was approved by the board of directors on 27th february 2008 and published on 28th february 2008. This annual report includes nonifrs financial measures such as core. Gsk annual report 2014 3 this year, in further efforts to improve our corporate reporting, we have incorporated more information about our responsible business approach and performance within the annual report as we move towards aligning with the principles of integrated reporting.
Annual report 2018 our annual report 2018 provides a comprehensive overview of novartis, including our corporate governance, compensation practices, and operating and financial results. If annual reports are published on our web page anyone interested in the research topic can read it and at the same time we can reduce the cost for publication. For years, we have focused on building the tools businesses need in the 21st century. This file contains additional information such as exif metadata which may have been added by the digital camera, scanner, or software program used to create or digitize it.
391 1342 1256 1612 1281 896 1185 1380 1395 433 991 811 98 1295 390 5 873 1142 420 1534 730 504 1612 514 105 1413 745 1601 1290 172 141 106 641 122 407 865 1259 795 367 217 936 589 1308